Protagenic therapeutics to present at the b. riley securities neuro and ophthalmology virtual investor conference on april 27th

New york, ny / accesswire / april 26, 2022 / protagenic therapeutics, inc. (nasdaq:ptix) a biopharmaceutical company focused on developing drug product candidates to treat stress-related neurologic disorders, today announced will be presenting at the b. riley securities neuro and ophthalmology virtual investor conference tomorrow, april 27, 2022.
PTIX Ratings Summary
PTIX Quant Ranking